article thumbnail

Leading API biologics (protein and peptide) companies in contract marketing

Pharmaceutical Technology

Pharmaceutical Technology has listed the leading API biologics (protein and peptide) companies in contract marketing based on its intel, insights, and decades-long experience in the sector.

Protein 130
article thumbnail

A new era in diagnostics: The growing demand for POC testing

Pharmaceutical Technology

“For strip devices, you have just a few processes for the device assembly,” says Jean-François Bauer, head of marketing and business development at Mikron Automation. “In In molecular devices, you have a lot of processes, and they are very complex because you are dealing with different reagents and with a variety of materials.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Calibre Scientific Expands European Presence and Chromatography Offering With AIT France Acquisition

The Pharma Data

Calibre Scientific is a diversified global provider of life science reagents, tools, instruments, and other consumables to the lab research, diagnostics, industrial, and biopharmaceutical communities. About Calibre Scientific. Source link.

article thumbnail

Changing Faces: pharma supplier, DTx, and non-profit hires from November 2022

pharmaphorum

Reagents supplier The Native Antigen Company has hired a new business development manager, Richard White , and senior product manager, Pardeep Sharda. Drawing on 25 years in clinical research, White will oversee Saama’s project delivery teams.

article thumbnail

What challenges does the advanced therapies sector face? 

Drug Discovery World

Natalia Elizalde, Chief Business Development Officer, VIVEbiotech, says that Dr Naldini’s award represents the significant benefits and demonstrated safety of the therapies developed using lentiviral vectors that are being used for more and more clinical trials and more prevalent diseases.

article thumbnail

Expert view: What’s next for cell and gene therapy?

Drug Discovery World

Lentiviral vectors demand Naiara Tejados, Head of Marketing and Technology Development at VIVEbiotech & Natalia Elizalde, Chief Business Development Officer at VIVEbiotech, anticipate that 2023 will be a very good year for VIVEbiotech, due to the increasing demand for lentiviral vectors.

article thumbnail

GenScript expands capacity for cell and gene therapy programmes

Drug Discovery World

“We are pleased to partner with these prestigious biotechnology companies in advancing cell therapies for the betterment of those that are sick and in need,” said Michael, Head of GMP Business Development at GenScript.